Search results for "carbamato"
showing 10 items of 17 documents
CCDC 139090: Experimental Crystal Structure Determination
2001
Related Article: G.Sanchez, F.Ruiz, J.L.Serrano, M.C.Ramirez de Arellano, G.Lopez|2000|Eur.J.Inorg.Chem.||2185|doi:10.1002/1099-0682(200010)2000:10<2185::AID-EJIC2185>3.0.CO;2-K
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the a…
2015
Chronic alcohol exposure reduces endocannabinoid activity and disrupts adult neurogenesis in rodents, which results in structural and functional alterations. Cannabinoid receptor agonists promote adult neural progenitor cell (NPC) proliferation. We evaluated the protective effects of the selective CB1 receptor agonist ACEA, the selective CB2 receptor agonist JWH133 and the fatty-acid amide-hydrolase (FAAH) inhibitor URB597, which enhances endocannabinoid receptor activity, on NPC proliferation in rats with forced consumption of ethanol (10%) or sucrose liquid diets for 2 weeks. We performed immunohistochemical and stereological analyses of cells expressing the mitotic phosphorylation of his…
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothal…
2015
Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamine…
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (C…
2019
Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…
CCDC 178510: Experimental Crystal Structure Determination
2003
Related Article: B.Macias, M.V.Villa, E.Chicote, S.Martin-Velasco, A.Castineiras, J.Borras|2002|Polyhedron|21|1899|doi:10.1016/S0277-5387(02)01098-7
CCDC 140466: Experimental Crystal Structure Determination
2001
Related Article: G.Sanchez, J.L.Serrano, M.C.Ramirez de Arellano, J.Perez, G.Lopez|2000|Polyhedron|19|1395|doi:10.1016/S0277-5387(00)00427-7
CCDC 157256: Experimental Crystal Structure Determination
2002
Related Article: G.Barone, T.Chaplin, T.G.Hibbert, A.T.Kana, M.F.Mahon, K.C.Molloy, I.D.Worsley, I.P.Parkin, L.S.Price|2002|J.Chem.Soc.,Dalton Trans.||1085|doi:10.1039/b108509n
CCDC 157258: Experimental Crystal Structure Determination
2002
Related Article: G.Barone, T.Chaplin, T.G.Hibbert, A.T.Kana, M.F.Mahon, K.C.Molloy, I.D.Worsley, I.P.Parkin, L.S.Price|2002|J.Chem.Soc.,Dalton Trans.||1085|doi:10.1039/b108509n
CCDC 161797: Experimental Crystal Structure Determination
2002
Related Article: O.Blacque, H.Brunner, M.M.Kubicki, J.-C.Leblanc, W.Meier, C.Moise, Y.Mugnier, A.Sadorge, J.Wachter, M.Zabel|2001|J.Organomet.Chem.|634|47|doi:10.1016/S0022-328X(01)01085-3
CCDC 161795: Experimental Crystal Structure Determination
2002
Related Article: O.Blacque, H.Brunner, M.M.Kubicki, J.-C.Leblanc, W.Meier, C.Moise, Y.Mugnier, A.Sadorge, J.Wachter, M.Zabel|2001|J.Organomet.Chem.|634|47|doi:10.1016/S0022-328X(01)01085-3